Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers

Worldwide screening for early detection of ovarian cancer in both, the general population and the group of women at high risk for ovarian cancer including BRCA genes mutations carriers, has proven to be ineffective. The recommended screening methods, including a pelvic examination, transvaginal ultr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ginekologia polska 2014-05, Vol.85 (5), p.377
Hauptverfasser:	Synowiec, Agnieszka, Wcisło, Gabriel, Bodnar, Lubomir, Gasowska-Bodnar, Agnieszka, Szczylik, Cezary
Format:	Artikel
Sprache:	eng ; pol
Schlagworte:	Biomarkers, Tumor Early Detection of Cancer - methods Evidence-Based Medicine Female Genes, BRCA1 Genes, BRCA2 Humans Mass Screening - organization & administration Mutation Neoplasm Staging Ovarian cancer Ovarian Neoplasms - diagnosis Ovarian Neoplasms - epidemiology Ovarian Neoplasms - genetics Ovarian Neoplasms - pathology Proteomics Sensitivity and Specificity Women's Health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!